title: Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
authors.forename: Mandie
authors.initials: M
authors.lastname: Romero
mesh_terms: D002626:Chemistry, Pharmaceutical; D002979:Climacteric / Q000187:drug effects* / Q000502:physiology; D004338:Drug Combinations; D004339:Drug Compounding; D016903:Drug Monitoring; D004958:Estradiol / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy / Q000009:adverse effects* / Q000379:methods*; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects; D004968:Estrogens, Non-Steroidal / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007529:Isoflavones; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects; D008593:Menopause / Q000187:drug effects* / Q000502:physiology; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D010347:Patient Care Planning; D048789:Phytoestrogens; D028321:Plant Preparations; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use
chemical_list: D004338:Drug Combinations; D004966:Estrogens, Conjugated (USP); D004968:Estrogens, Non-Steroidal; D007529:Isoflavones; D048789:Phytoestrogens; D028321:Plant Preparations; C466383:Prempro; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride; D004958:Estradiol; D017258:Medroxyprogesterone Acetate